Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report

The purpose of this case report was to be alert to the possibility of side effects such as neutropenia due to antipsychotic drugs and to draw attention to the management of these patients

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Changes in blood parameters may occur during the use of psychiatric drugs.

📊

Key Findings & Data:In such cases, the general condition of the patient and the blood parameters are closely monitored and the treatment is discontinued or the medication is changed.

💡

Conclusion & Impact:The purpose of this case report was to be alert to the possibility of side effects such as neutropenia due to antipsychotic drugs and to draw attention to the management of these patients

🔬Design:Case Report

📍Scope:Comprehensive Sample

⚙️Variables:Antipsychotic medications · Antiepileptic drugs · Neutropenia

Abstract

Changes in blood parameters may occur during the use of psychiatric drugs. In such cases, the general condition of the patient and the blood parameters are closely monitored and the treatment is discontinued or the medication is changed. The purpose of this case report was to be alert to the possibility of side effects such as neutropenia due to antipsychotic drugs and to draw attention to the management of these patients

Özet

Psikiyatrik ilaçların kullanımı sırasında kan parametrelerinde değişiklikler meydana gelebilir. Bu gibi durumlarda hastanın genel durumu ve kan parametreleri yakından takip edilerek tedavi kesilir veya ilaç değiştirilir. Bu vaka raporunun amacı, antipsikotik ilaçlara bağlı nötropeni gibi yan etki olasılığına karşı uyanık olmak ve bu hastaların yönetimine dikkat çekmekti.

Keywords

Antipsychotic medications Antiepileptic drugs Neutropenia

🔖

Cite This Article

Mehmetaj, L., Ugur, Y., Taslidere, B., Sonmez, E., Cander, B. (2022). Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report. Eurasian Journal of Toxicology, Volume: 4 Issue: 2. https://doi.org/10.51262/ejtox.1162734

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Bonilla MA. Disorders of white blood cells. In Manual of Pediatric Hematology and Oncology, Lanzkowsky ed, 5th edition, Amsterdam, Elsevier, 2011, p:272-320
Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp. 2008; 23(1): 27-41
Uetrecht JP. Reactive metabolites and agranulocytosis. Eur J Haematol Suppl. 1996; 60: 83-88
Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004; 107 (1): 1-16. doi: 10.1016/j.clineuro.2004.07.012.
Nair P, Lippmann S. Is leukopenia associated with divalproex and/or quetiapine? Can J Psychiatry. 2003; 48: 65-66
Bartels M, van Solinge WW, den Breeijen HJ, Bierings MB, Coffer PJ, Egberts TCG. Valproic acid treatment is associated with altered leukocyte subset development. J Clin Psychopharmacol. 2012; 32: 832–4
Rahman A, Mican LM, Fischer C, Campbell AH. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Ann Pharmacother. 2009; 43: 822-830
Petrini M, Azzarà A. Lithium in the treatment of neutropenia. Curr Opin Hematol. 2012; 19(1): 52-7. doi: 10.1097/MOH.0b013e32834da93b
Yılmaz G, Erten E, Fıstıkcı N, Erek S, Saatcioglu O. Antipsikotik Kullanımıyla Tetiklenen Nötropeni Olgusunda Tedaviye Lityum Eklenmesi. Düşünen Adam The Journal of Psychiatry and Neurological Sciences. 2014; 27: 78-80 doi: 10.5350/DAJPN2014270111
Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004; 107 (1): 1-16. doi: 10.1016/j.clineuro.2004.07.012.